To read this content please select one of the options below:

Ischaemic heart disease guidelines and cardiac medications use in veterans administration hospitals

Britta I. Neugaard (Britta I. Neugaard is a Health Service Researcher at the Rehabilitation Outcomes Research Centre, North Florida/South Georgia VA, Gainseville, Florida, USA.)
Robert G. Zoble (Robert G. Zoble is Director, Coronary Care Unit for the James A. Haley Veterans Hospital, Tampa, Florida, USA.)
Jason W. Beckstead (Jason W. Beckstead is Assistant Professor, University of South Florida, Tampa, Florida, USA.)
Audrey L. Nelson (Audrey L. Nelson is Director of the Patient Safety Center of the James A. Haley Veterans Hospital, Tampa, Florida, USA.)

Clinical Governance: An International Journal

ISSN: 1477-7274

Article publication date: 1 December 2003

503

Abstract

This study was designed to determine if health care provider utilization of cardiac medications has been influenced by the US Department of Veterans Affairs (VA) ischemic heart disease (IHD) guidelines dissemination. Retrospective chart reviews were conducted on a random sample of 1,397 IHD patients at six VA hospitals. Use of IHD medications was high even in the pre‐IHD guideline period, which may explain the lack of observed differences between the pre‐ and post‐guideline dissemination eras.

Keywords

Citation

Neugaard, B.I., Zoble, R.G., Beckstead, J.W. and Nelson, A.L. (2003), "Ischaemic heart disease guidelines and cardiac medications use in veterans administration hospitals", Clinical Governance: An International Journal, Vol. 8 No. 4, pp. 300-307. https://doi.org/10.1108/14777270310499388

Publisher

:

MCB UP Ltd

Copyright © 2003, MCB UP Limited

Related articles